Corpus Intelligence IC Memo — LAKELAND MEDICAL CENTER ST. JOSEPH 2026-04-26 05:27 UTC
IC Memo — LAKELAND MEDICAL CENTER ST. JOSEPH
Investment Committee Memorandum | MI | 235 beds | Grade B | EBITDA uplift $35.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LAKELAND MEDICAL CENTER ST. JOSEPH

CCN 230021 | BERRIEN, MI | 235 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

LAKELAND MEDICAL CENTER ST. JOSEPH is a 235-bed suburban community hospital in BERRIEN, MI with $488.2M in net patient revenue and a -3.6% operating margin. The hospital serves a payer mix of 25.9% Medicare, 6.9% Medicaid, and 67.3% commercial.

Thesis: Undervalued. Our ML models identify $35.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.6% to 3.8% (+736bps).

Net Revenue HCRIS$488.2M
Current EBITDA COMPUTED$-17.5M
Operating Margin COMPUTED-3.6%
Occupancy HCRIS64.9%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS34.0%
Distress Probability ML44.9%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
51
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -3.6% places it above the state median. Among 51 size-comparable peers (118-470 beds), the median margin is -7.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (118-470), prioritizing same-state peers. 51 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LAKELAND MEDICAL CENTER ST. J (Target)MI235$488.2M-3.6%
BRONSON METHODIST HOSPITALMI439$1.06B-1.4%
EDWARD W. SPARROW HOSPITALMI425$936.1M-24.5%
MUNSON MEDICAL CENTERMI401$710.9M-7.0%
W.A. FOOTE MEMORIAL HOSPITALMI331$681.8M-9.0%
COVENANT MEDICAL CENTERMI464$680.9M-10.5%
TRINITY HEALTH MUSKEGONMI262$621.2M-15.5%
TRINITY HEALTH GRAND RAPIDSMI271$601.8M-27.3%
HENRY FORD HEALTH MACOMB HOSPIMI303$584.5M-6.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $35.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$10.3M+210bp18mo
Cost to Collect4.5%2.5%$9.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$9.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$5.9M+122bp9mo
Clean Claim Rate88.0%96.0%$312K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$10.3M
Cost to Collect
$9.8M
Denial Rate Reduction
$9.7M
A/R Days Reduction
$5.9M
Clean Claim Rate
$312K
Total EBITDA Uplift$35.9M
Current EBITDA$-17.5M
+ RCM Uplift+$35.9M
Pro Forma EBITDA$18.4M
Current Margin-3.6%
Pro Forma Margin3.8%
WC Released (1x)$18.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-26.9M$244.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-26.9M$259.7M0.00x-100.0%
Bull Case9.0x11.0x$-24.2M$369.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-24.2M$396.0M0.00x-100.0%
Bear Case11.0x10.0x$-29.6M$73.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-29.6M$70.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 51 hospitals with 118-470 beds
  • Same-state prioritization (n=52)
  • Comp margins: P25=-14.3% / P50=-7.7% / P75=-0.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.